Medical devices, healthcare technology and the business of care
510(k) clearance · K253578

BriefCase-Triage: CARE Multi-Triage CT for Pneumothorax; Pericardial effusion; Large aortic aneurysm; Shoulder fracture or dislocation device

Aidoc Medical , Ltd. · Decision date Feb 26, 2026

FDA DECISIONK253578

What did the FDA decide?

FDA records K253578 as a 510(k) premarket notification, with a decision dated Feb 26, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Feb 26, 2026

FDA source record

Regulatory record facts

Identifier
K253578
Regulatory pathway
510(k) premarket notification
Product code
QAS
Decision code
SESE
Decision date
Feb 26, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Radiological Computer-Assisted Triage And Notification Software.

Product code
QAS
FDA device class
2

FDA decision timeline

  1. K253578 received

    Application receipt date recorded by FDA.

  2. K253578 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QAS

Product / regulatory recordCompanyPathwayDecision dateSource
Ever Fortune.Ai, Co., Ltd.510(k) clearanceOct 30, 2026FDA
Ischemaview, Inc.510(k) clearanceOct 9, 2026FDA
A2z Radiology Ai, Inc.510(k) clearanceSep 16, 2026FDA
iSchemaview510(k) clearanceJul 13, 2026FDA
GuideAI Health510(k) clearanceJun 18, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Aidoc Medical , Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Tel Aviv

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records